Association of HLA-DR-DQ alleles, haplotypes, and diplotypes with type 1 diabetes in Saudis. 2020

Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
Department of Pathology and Clinical Laboratory Medicine, King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.

Type 1 diabetes (T1D) is an autoimmune disease that affects many children worldwide. Genetic factors and environmental triggers play crucial interacting roles in the aetiology. This study aimed to assess the contribution of HLA-DRB1-DQA1-DQB1 alleles, haplotypes, and genotypes to the risk of T1D among Saudis. A total of 222 children with T1D and 342 controls were genotyped for HLA-DRB1, -DQA1, and -DQB1 using reverse sequence-specific oligonucleotide (rSSO) Lab Type high definition (HD) kits. Alleles, haplotypes, and diplotypes were compared between cases and controls using the SAS statistical package. DRB1*03:01-DQA1*05:01-DQB1*02:01 (32.4%; OR = 3.68; Pc < .0001), DRB1*04:05-DQA1*03:02-DQB1*03:02 (6.6%; OR = 6.76; Pc < .0001), DRB1*04:02-DQA1*03:01-DQB1*03:02 (6.0%; OR = 3.10; Pc = .0194), DRB1*04:01-DQA1*03:01-DQB1*03:02 (3.7%; OR = 4.22; Pc = .0335), and DRB1*04:05-DQA1*03:02-DQB1*02:02 (2.7%; OR = 6.31; Pc = .0326) haplotypes were significantly increased in cases compared to controls, whereas DRB1*07:01-DQA1*02:01-DQB1*02:02 (OR = 0.41; Pc = .0001), DRB1*13:01-DQA1*01:03-DQB1*06:03 (OR = 0.05; Pc < .0001), DRB1*15:01-DQA1*01:02-DQB1*06:02 (OR = 0.03; Pc < .0001), and DRB1*11:01-DQA1*05:05-DQB1*03:01 (OR = 0.07; Pc = .0291) were significantly decreased. Homozygous DRB1*03:01-DQA1*05:01-DQB1*02:01 genotypes and combinations of DRB1*03:01-DQA1*05:01-DQB1*02:01 with DRB1*04:05-DQA1*03:02-DQB1*03:02, DRB1*04:02-DQA1*03:01-DQB1*03:02, and DRB1*04:01-DQA1*03:01-DQB1*03:02 were significantly increased in cases than controls. Combinations of DRB1*03:01-DQA1*05:01-DQB1*02:01 with DRB1*07:01-DQA1*02:01-DQB1*02:02 and DRB1*13:02-DQA1*01:02-DQB1*06:04 showed low OR values but did not remain significantly decreased after Bonferroni correction. HLA-DRB1-DQA1-DQB1 alleles, haplotypes, and diplotypes in Saudis with T1D are not markedly different from those observed in Western and Middle-Eastern populations but are quite different than those of East Asians.

UI MeSH Term Description Entries
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D004171 Diploidy The chromosomal constitution of cells, in which each type of CHROMOSOME is represented twice. Symbol: 2N or 2X. Diploid,Diploid Cell,Cell, Diploid,Cells, Diploid,Diploid Cells,Diploidies,Diploids
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
January 2020, Endocrine, metabolic & immune disorders drug targets,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
June 2009, Human immunology,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
September 2016, Nephrology (Carlton, Vic.),
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
July 1999, Gastroenterology,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
April 2008, Diabetes,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
February 2002, Diabetes,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
April 2017, HLA,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
October 2019, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
February 2000, Experimental and molecular pathology,
Nezar Eltayeb-Elsheikh, and Eltahir Khalil, and Mohamed Mubasher, and Abdullah AlJurayyan, and Hanan AlHarthi, and Waleed H Omer, and Inas Elghazali, and Suphia M Sherbeeni, and Mohammed A Alghofely, and Jorma Ilonen, and Gehad Elghazali
August 2006, Human immunology,
Copied contents to your clipboard!